483
The Blood CenterFDA 483 - The Blood Center - June 17, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of The Blood Center in New Orleans, LA, from June 13-17, 2022, revealed significant deficiencies in quality control and documentation practices. Observations included failures to thoroughly investigate temperature excursions of blood components, maintain adequate records, and adhere to standard operating procedures for storage and transfer. The firm also failed to submit a required biological product deviation report within the specified timeframe.
Open in Dashboard
ID · 32d2581b-1223-406b-8b6e-d757e2bf8fb2